Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy

By Michael Keidar, R. Walk, A. Shashurin, Priya Srinivasan, A. Sandler, S. Dasgupta, R. Ravi, Rafael Guerrero-Preston, B. Trink. British Journal of Cancer, 2011

712 citations recorded by the source corpus.

Background:Plasma is an ionised gas that is typically generated in high-temperature laboratory conditions. However, recent progress in atmospheric plasmas has led to the creation of cold plasmas with ion temperature close to room temperature.Methods:Both in-vitro and in-vivo studies revealed that cold plasmas selectively kill cancer cells.Results:We show that: (a) cold plasma application selectively eradicates cancer cells in vitro without damaging normal cells; and (b) significantly reduces tumour size in vivo. It is shown that reactive oxygen species metabolism and oxidative stress responsive genes are deregulated.Conclusion:The development of cold plasma tumour ablation has the potential of shifting the current paradigm of cancer treatment and enabling the transformation of cancer treatment technologies by utilisation of another state of matter.

Subfields: Aerospace Engineering, Electrical and Electronic Engineering, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/156ff8d4d90b1a3bc0028c5b7f427606703cc56e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. O. Penkov
  2. Dae‐Eun Kim
  3. K. Kitano
  4. M. Khadem
  5. Y. Nakashima
  6. A. Tani
  7. Won-Suk Lim
  8. S. Ikawa

Citations in the corpus